GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Lab] 14th independent test on BCH, and the trend is the interesting part — 13 comments in the full submission. View in context.
77
c/trialwatch·submitted 1 months ago by u/yara_mensah

[Lab] 14th independent test on BCH, and the trend is the interesting part

Press Releasebranch of 8 comments

I have had 2 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied by about 22 days on nominally the same lane, which matters more in summer than in February. The independent number came back 99.0% against a claimed…

Read the full submission and all 13 comments →

This branch

8 comments, started 1 months ago
u/tomas_kimani8 points·1 months ago

the discontinuation arms are the interesting part, not the SURPASS endpoints

replysharereportpermalink
u/hazard_ratio_halstats2 points·1 months ago

STEP 1 readout: 98.6% mean weight loss, absolute numbers matter. Spread around that mean is enormous.

replysharereportpermalink
u/yara_mensahOP1 point·1 months ago

STEP 1 readout: 93.7% mean weight loss, absolute numbers matter. Spread around that mean is enormous.

replysharereportpermalink
u/heart_rate_bump1 point·1 months ago

Is that absolute or relative risk reduction?

replysharereportpermalink
u/yara_mensahOP1 point·1 months ago

phase 2 is not phase 3, smaller n and shorter trial

replysharereportpermalink
u/yara_mensahOP1 point·1 months ago

STEP 1 readout: 97.6% mean weight loss, absolute numbers matter. Spread around that mean is enormous.

replysharereportpermalink
u/rulebook_rachaelmod · c/meta2 points·1 months ago·edited

Strongly agree. Phase 2 is investigational, not conclusive.

replysharereportpermalink
u/emil_agyeman1 point·1 months ago

STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.comSponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →